@article{Sánchez-Espín_Rodríguez-Capitán_Otero Forero_Becerra Muñoz_Rodríguez Caulo_Such-Martínez_Porras-Martín_Villaescusa-Catalán_Mataró-López_Guzón-Rementería_Melero-Tejedor_Gutiérrez-Carretero_Jiménez Navarro_2020, title={Outcomes of Isolated Tricuspid Valve Surgery}, volume={23}, url={https://journal.hsforum.com/index.php/HSF/article/view/3093}, DOI={10.1532/hsf.3093}, abstractNote={<p class="p1"><span class="s1"><strong>Background:</strong> Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation.</span></p> <p class="p1"><span class="s2"><strong>Methods:</strong> This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up.</span></p> <p class="p1"><span class="s2"><strong>Results:</strong> Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; <br /><em>P</em> = 0.038). At the end of follow up, 63.6% of survivors had functional class I.</span></p> <p class="p1"><span class="s2"><strong>Conclusions:</strong> Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.</span></p>}, number={6}, journal={The Heart Surgery Forum}, author={Sánchez-Espín, Gemma and Rodríguez-Capitán, Jorge and Otero Forero, Juan José and Becerra Muñoz, Víctor Manuel and Rodríguez Caulo, Emiliano Andrés and Such-Martínez, Miguel and Porras-Martín, Carlos and Villaescusa-Catalán, José Manuel and Mataró-López, María José and Guzón-Rementería, Aranta and Melero-Tejedor, José María and Gutiérrez-Carretero, Encarnación and Jiménez Navarro, Manuel Francisco}, year={2020}, month={Oct.}, pages={E763-E769} }